Literature DB >> 32719836

Phenoxazine-based scaffold for designing G4-interacting agents.

Vladimir B Tsvetkov1, Anna M Varizhuk2, Sofia A Lizunova3, Tatiana A Nikolenko3, Igor A Ivanov4, Vjacheslav V Severov5, Evgeny S Belyaev6, Egor A Shitikov5, Galina E Pozmogova5, Andrey V Aralov4.   

Abstract

G-quadruplexes (G4) represent one class of non-canonical secondary nucleic acid structures that are currently regarded as promising and attractive targets for anti-cancer, anti-viral and antibacterial therapy. Herein, we probe a new i-clamp-inspired phenoxazine scaffold for designing G4-stabilizing ligands. The length of the protonated aminoalkyl tethers ('arms') of the phenoxazine-based ligand was optimized in silico. Two double-armed ligands differing in the relative orientation of their arms and one single-armed ligand were synthesized. The two-armed ligands significantly enhanced the thermal stability of the G-quadruplex structures (increasing the melting temperature by up to 20 °C) and displayed G4 selectivity over duplex DNA. The ligands look promising for biological studies and the phenoxazine scaffold could be a starting point for designing new G4-interacting compounds.

Entities:  

Year:  2020        PMID: 32719836     DOI: 10.1039/d0ob00983k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Synthesis and investigation of quadruplex-DNA-binding, 9-O-substituted berberine derivatives.

Authors:  Jonas Becher; Daria V Berdnikova; Heiko Ihmels; Christopher Stremmel
Journal:  Beilstein J Org Chem       Date:  2020-11-18       Impact factor: 2.883

2.  Probing GFP Chromophore Analogs as Anti-HIV Agents Targeting LTR-III G-Quadruplex.

Authors:  Dmitriy Y Ryazantsev; Mikhail Yu Myshkin; Vera A Alferova; Vladimir B Tsvetkov; Elena Y Shustova; Polina N Kamzeeva; Polina V Kovalets; Elvira R Zaitseva; Nadezhda S Baleeva; Timofei S Zatsepin; Zakhar O Shenkarev; Mikhail S Baranov; Liubov I Kozlovskaya; Andrey V Aralov
Journal:  Biomolecules       Date:  2021-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.